Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Core Scientific (CORZ) Net Income towards Common Stockholders (2020 - 2026)

Core Scientific has reported Net Income towards Common Stockholders over the past 7 years, most recently at -$347.2 million for Q1 2026.

  • Quarterly results put Net Income towards Common Stockholders at -$347.2 million for Q1 2026, down 160.25% from a year ago — trailing twelve months through Mar 2026 was -$1.2 billion (down 13.04% YoY), and the annual figure for FY2025 was -$288.6 million, up 79.93%.
  • Net Income towards Common Stockholders reached -$347.2 million in Q1 2026 per CORZ's latest filing, down from $216.0 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $576.3 million in Q1 2025 and bottomed at -$936.8 million in Q2 2025.
  • Median Net Income towards Common Stockholders over the past 5 years was -$291.1 million (2024), compared with a mean of -$262.7 million.
  • The largest annual shift saw Net Income towards Common Stockholders crashed 23638.28% in 2022 before it skyrocketed 54967.45% in 2024.
  • Over 5 years, Net Income towards Common Stockholders stood at -$434.8 million in 2022, then surged by 55.0% to -$195.7 million in 2023, then plummeted by 48.78% to -$291.1 million in 2024, then surged by 174.18% to $216.0 million in 2025, then tumbled by 260.76% to -$347.2 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for CORZ at -$347.2 million in Q1 2026, $216.0 million in Q4 2025, and -$144.0 million in Q3 2025.